Comparisons of serum miRNA expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitus
Authors:
Open Access
Abstract
The aim of this study was to compare the expression levels of serum miRNAs in diabetic retinopathy and type 2 diabetes mellitus. Serum miRNA expression profiles from diabetic retinopathy cases (type 2 diabetes mellitus patients with diabetic retinopathy) and type 2 diabetes mellitus controls (type 2 diabetes mellitus patients without diabetic retinopathy) were examined by miRNA-specific microarray analysis. Quantitative real-time polymerase chain reaction was used to validate the significantly differentially expressed serum miRNAs from the microarray analysis of 45 diabetic retinopathy cases and 45 age-, sex-, body mass index- and duration-of-diabetes-matched type 2 diabetes mellitus controls. The relative changes in serum miRNA expression levels were analyzed using the 2-ΔΔCt method. A total of 5 diabetic retinopathy cases and 5 type 2 diabetes mellitus controls were included in the miRNA-specific microarray analysis. The serum levels of miR-3939 and miR-1910-3p differed significantly between the two groups in the screening stage; however, quantitative real-time polymerase chain reaction did not reveal significant differences in miRNA expression for 45 diabetic retinopathy cases and their matched type 2 diabetes mellitus controls. Our findings indicate that miR-3939 and miR-1910-3p may not play important roles in the development of diabetic retinopathy; however, studies with a larger sample size are needed to confirm our findings.Keywords
This publication has 27 references indexed in Scilit:
- Accuracy of microRNAs for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysisClinics and Research in Hepatology and Gastroenterology, 2016
- Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a reviewClinical & Experimental Ophthalmology, 2016
- MicroRNA-152 represses VEGF and TGFβ1 expressions through post-transcriptional inhibition of (Pro)renin receptor in human retinal endothelial cells2015
- MicroRNA-410 Reduces the Expression of Vascular Endothelial Growth Factor and Inhibits Oxygen-Induced Retinal NeovascularizationPLOS ONE, 2014
- Profiling of Circulating MicroRNAs Reveals Common MicroRNAs Linked to Type 2 Diabetes That Change With Insulin SensitizationDiabetes Care, 2014
- Increased MicroRNA-146a Levels in Plasma of Patients with Newly Diagnosed Type 2 Diabetes MellitusPLOS ONE, 2013
- Extracellular microRNA: A new source of biomarkersMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2011
- MicroRNA-200b Regulates Vascular Endothelial Growth Factor–Mediated Alterations in Diabetic RetinopathyDiabetes, 2011
- Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical studyActa Diabetologica, 2010
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001